Aryl-hydrocarbon receptor dysregulation and its correlation with immunomodulatory markers in COVID-19 patients
- PMID: 40591212
- DOI: 10.1007/s10787-025-01828-5
Aryl-hydrocarbon receptor dysregulation and its correlation with immunomodulatory markers in COVID-19 patients
Abstract
Introduction: The COVID-19 pandemic with various clinical symptoms has posed significant challenges to the healthcare system. The aryl-hydrocarbon receptor (AhR), a transcription factor that can be activated by both external and internal ligands, may play a role in the regulation of pro-inflammatory cytokines, including interleukin (IL)-6. Additionally, indoleamine-2,3-dioxygenase (IDO)-1 is thought to have an immunomodulatory role and provides kynurenine, an AhR agonist. This research aimed to examine the alteration of AhR and IDO-1 gene expression in patients diagnosed with COVID-19 as well as evaluate their correlation with IL-6 and interferon (IFN)-α serum levels.
Methods: A total of 30 patients diagnosed with COVID-19, along with 30 healthy individuals matched for age and gender, were chosen to serve as the control group. The gene expressions of AhR and IDO-1 were assessed using RT-PCR as well as the serum concentration of IL-6 was measured using ELISA techniques.
Results: The results showed an increased level of AhR gene expression (p value: 0.017), and elevated serum levels of IL-6 (p value: 0.044) in the patients with COVID analyzed alongside the control group. However, IDO-1 gene expression was slightly downregulated. IFN-α serum levels were comparable between the two groups. AhR gene expression had a weak negative correlation with IDO-1 expression. Neither IL-6 nor IFN-α showed a correlation with AhR expression; nonetheless, IL-6 demonstrated an increasing pattern by disease severity.
Conclusion: This study's outcomes revealed a dysregulated expression of AhR and IDO-1 in COVID-19 patients. IL-6 was elevated, but IDO-1 as an immunomodulatory molecule was suppressed. Besides, AhR expression showed no correlation with IDO-1, IL-6, or IFN-α levels.
Keywords: Aryl hydrocarbon receptor; COVID-19; Indoleamin2,3-dioxygenase-1; Interferon-alpha; Interleukin-6.
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflicts of interest. Ethical approval: All the techniques carried out in the present study involving human participants were in accordance with the standards of the institutional research committee and with the Helsinki declaration and its later amendments or comparable ethical standards. It has ethical approval of Tehran University of medical sciences (Code: IR.TUMS.CHMC.REC.1401.131). Informed consent was obtained from all participants after describing the process and goals of the study.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
IDO1-AhR axis increases T regulatory cells in Plasmodium vivax malaria infection.Front Immunol. 2025 Jul 14;16:1474447. doi: 10.3389/fimmu.2025.1474447. eCollection 2025. Front Immunol. 2025. PMID: 40726977 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Ahmadi M et al (2024) Aryl hydrocarbon receptor gene expression in ankylosing spondylitis and its correlation with interleukin-17, RAR-related orphan receptor gamma t expression, and disease activity indices. Archives of Rheumatology 39(1):123–132 - PubMed
-
- Baban B et al (2009) IDO activates regulatory T cells and blocks their conversion into Th17-like T cells1. J Immunol 183(4):2475–2483 - PubMed
-
- Chen X et al (2020) Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. MedRxiv 2020:20029520
Grants and funding
LinkOut - more resources
Research Materials